Pharmaceutical Economics & Health Policy| Volume 20, ISSUE 1, P169-181, January 1998

Costs and duration of care for lower extremity ulcers in patients with diabetes

      This paper is only available as a PDF. To read, Please Download here.


      Medical and pharmaceutical insurance claims associated with lower extremity diabetic ulcers were examined retrospectively to better understand the costs and duration of treatment in clinical practice. The study population consisted of working-age individuals (18 to 64 years old) with health care benefits provided through private employer-sponsored insurance plans. Diagnostic information contained in the claims database was used to identify the severity of the ulcers, and the charges associated with treatment were based on claims data. Claims for lower extremity ulcers were found in 5.1% of individuals with diabetes. Although many lower extremity ulcers heal with standard treatment, some are more resistant to treatment and require costly ongoing medical care. Almost half of these cases were associated with deep infection, osteomyelitis, or amputation. Total payments for treatment of lower extremity ulcers in this population averaged $2687 per patient per year, or $4595 per ulcer episode, with inpatient expenditures accounting for more than 80% of these costs. Costs were significantly higher for patients with more severe ulcers or with inadequate vascular status in the affected limb. We concluded that lower extremity ulcers occur in a large number of working-age people with diabetes and contribute significantly to the morbidity associated with this disease. The high cost of treating diabetic foot ulcers suggested by this analysis argues for the development of better treatment strategies and outcomes assessments for these patients.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Clinical Therapeutics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Harris MI
        (In: National Diabetes Data Group)in: Diabetes in America. National Institutes of Health, Bethesda, Md1995: 1-14
        • Palumbo PJ
        • Melton III, LJ
        Peripheral vascular disease and diabetes.
        in: Harris MI Hamman RF Diabetes in America. US Government Printing Office, Washington, DC1985: 1-21
        • Reiber GE
        The epidemiology of diabetic foot problems.
        Diabetic Med. 1996; 13 (Suppl 1): S6-S11
        • Walters DP
        • Gatling W
        • Mullee MA
        • Hill RD
        The distribution and severity of diabetic foot disease: A community study with comparison to a non-diabetic group.
        Diabetic Med. 1992; 9: 354-358
        • Borssén B
        • Bergenheim T
        • Lithner F
        The epidemiology of foot lesions in diabetic patients aged 15–50 years.
        Diabetic Med. 1990; 7: 438-444
        • Moss SE
        • Klein R
        • Klein BEK
        The prevalence and incidence of lower extremity amputation in a diabetic population.
        Arch Intern Med. 1992; 152: 610-616
        • Reiber GE
        • Boyko EJ
        • Smith G
        Lower extremity foot ulcers and amputation in diabetes.
        (In: National Diabetes Data Group)in: Diabetes in America. National Institutes of Health, Bethesda, Md1995: 409-428
        • Grunfeld C
        Diabetic foot ulcers: Etiology, treatment, and prevention.
        Adv Intern Med. 1991; 37: 103-132
        • Glover JL
        • Weingarten MS
        • Buchbinder DS
        • et al.
        A 4-year outcome-based retrospective study of wound healing and limb salvage in patients with chronic wounds.
        Adv Wound Care. 1997; 1: 33-38
        • Ragnarson-Tenmvall G
        • Apelqvist J
        Cost-effective management of diabetic foot ulcers.
        PharmacoEconomics. 1997; 12: 42-53
        • Apelqvist J
        • Ragnarson-Tenmvall G
        • Persson U
        • et al.
        Diabetic foot ulcers in a multidisciplinary setting: An economic analysis of primary healing and healing with amputation.
        J Intern Med (GBR). 1994; 235: 463-471
        • Criado E
        • de Stefano AA
        • Keagy BA
        • et al.
        The course of severe foot infection in patients with diabetes.
        Surg Gynecol Obstet. 1992; 175: 135-140
        • Apelqvist J
        • Agardh C-D
        The association between clinical risk factors and outcome of diabetic foot ulcers.
        Diabetes Res Clin Pract. 1992; 18: 43-53
        • LoGerfo FW
        • Gibbons GW
        • Pomposelli Jr, FB
        • et al.
        Trends in the care of the diabetic foot. Expanded role of arterial reconstruction.
        Arch Surg. 1992; 127: 617-621
        • Gibbons GW
        • Marcaccio Jr, EJ
        • Burgess AM
        • et al.
        Improved quality of diabetic foot care, 1984 vs 1990. Reduced length of stay and costs, insufficient reimbursement.
        Arch Surg. 1993; 128: 576-581
        • Raviola CA
        • Nichter LS
        • Baker JD
        • et al.
        Cost of treating advanced leg ischemia. Bypass graft vs primary amputation.
        Arch Surg. 1988; 123: 495-496
        • Grestman BB
        • Freiman JP
        • Hine LK
        Use of subsequent anticoagulants to increase the predictive value of Medicaid deep venous thromboembolism diagnoses.
        Epidemiology. 1990; 1: 122-127
        • Malenka DJ
        • McLerran D
        • Roos N
        • et al.
        Using administrative data to describe casemix: A comparison with the medical record.
        J Clin Epidemiol. 1994; 47: 1027-1032
        • Ma LQ
        • Ellis LBM
        • Venus P
        • et al.
        Using claims data for epidemiologic research.
        Med Care. 1993; 41: 498-507
        • Javitt JC
        • McBean AM
        • Sastry SS
        • DiPaolo F
        Accuracy of coding in Medicare part B claims.
        Arch Ophthalmol. 1993; 111: 605-607
        • Romano PS
        • Roos LL
        • Luft HS
        • et al.
        The ischemic heart disease patient outcomes research team. A comparison of administrative versus clinical data: Coronary artery bypass surgery as an example.
        J Clin Epidemiol. 1994; 47: 249-260
        • Roos LL
        • Sharp SM
        • Cohen MM
        Comparing clinical information with claims data: Some similarities and differences.
        J Clin Epidemiol. 1991; 44: 881-888
        • Robinson JR
        • Young TK
        • Roos LL
        • Gelskey DE
        Estimating the burden of disease: Comparing administrative data and self-reports.
        Med Care. 1997; 35: 932-947
        • Jollis JG
        • Ancukiewicz M
        • DeLong ER
        • et al.
        Discordance of databases designed for claims payment versus clinical information systems.
        Ann Intern Med. 1993; 119: 844-850